-inc-logo-1200x675.png){kind=logo}
Mind Medicine (MindMed) Inc. (OTCMKTS:MMEDF – Get Free Report)’s stock price shot up 12.9% on Friday . The company traded as high as $9.15 and last traded at $8.49. 4,633,673 shares traded hands during mid-day trading, an increase of 37% from the average session volume of 3,376,665 shares. The stock had previously closed at $7.52.
Mind Medicine (MindMed) Trading Up 12.9 %
The company’s fifty day simple moving average is $6.00 and its 200-day simple moving average is $7.24.
Mind Medicine (MindMed) Company Profile
Mind Medicine (MindMed) Inc, a psychedelic medicine biotech company, discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances, including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC.
See Also
- Five stocks we like better than Mind Medicine (MindMed)
- What Investors Need to Know About Upcoming IPOs
- Dot Ai IPO: CEO Ed Nabrotzky Shares Vision for Logistics Future
- What Makes a Stock a Good Dividend Stock?
- The Hottest Markets to Watch After the Fed’s 25 Bps Rate Cut
- What Are Growth Stocks and Investing in Them
- The Top 5 Performing S&P 500 Stocks YTD in 2024
Receive News & Ratings for Mind Medicine (MindMed) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mind Medicine (MindMed) and related companies with MarketBeat.com's FREE daily email newsletter.
